ALBENDAZOLE
Antiparasitic
Strength400 mg
Formoral.solid
10-15 mg/kg/day in two divided doses, each dose capped at 400 mg x 1 to 6 months, decided by the cyst stage and the response
5-7.5 mg/kg/dose [child max 400 mg]
(Hydatid disease in children and adolescents: 5-7.5 mg/kg per dose twice daily for 1 to 6 months, each dose capped at 400 mg. The grid above is per dose, not per day - twice this amount is given in 24 hours.)
| 3kg | 15-22.5 mg/dose |
|---|---|
| 4kg | 20-30 mg/dose |
| 5kg | 25-37.5 mg/dose |
| 6kg | 30-45 mg/dose |
| 7kg | 35-52.5 mg/dose |
| 8kg | 40-60 mg/dose |
| 9kg | 45-67.5 mg/dose |
| 10kg | 50-75 mg/dose |
| 11kg | 55-82.5 mg/dose |
| 12kg | 60-90 mg/dose |
| 13kg | 65-97.5 mg/dose |
| 14kg | 70-105 mg/dose |
| 15kg | 75-112.5 mg/dose |
| 16kg | 80-120 mg/dose |
| 17kg | 85-127.5 mg/dose |
| 18kg | 90-135 mg/dose |
| 19kg | 95-142.5 mg/dose |
| 20kg | 100-150 mg/dose |
| 21kg | 105-157.5 mg/dose |
| 22kg | 110-165 mg/dose |
| 23kg | 115-172.5 mg/dose |
| 24kg | 120-180 mg/dose |
| 25kg | 125-187.5 mg/dose |
| 26kg | 130-195 mg/dose |
| 27kg | 135-202.5 mg/dose |
| 28kg | 140-210 mg/dose |
| 29kg | 145-217.5 mg/dose |
| 30kg | 150-225 mg/dose |
| 31kg | 155-232.5 mg/dose |
| 32kg | 160-240 mg/dose |
| 33kg | 165-247.5 mg/dose |
| 34kg | 170-255 mg/dose |
| 35kg | 175-262.5 mg/dose |
| 36kg | 180-270 mg/dose |
| 37kg | 185-277.5 mg/dose |
| 38kg | 190-285 mg/dose |
| 39kg | 195-292.5 mg/dose |
| 40kg | 200-300 mg/dose |
| 41kg | 205-307.5 mg/dose |
| 42kg | 210-315 mg/dose |
| 43kg | 215-322.5 mg/dose |
| 44kg | 220-330 mg/dose |
| 45kg | 225-337.5 mg/dose |
| 46kg | 230-345 mg/dose |
| 47kg | 235-352.5 mg/dose |
| 48kg | 240-360 mg/dose |
| 49kg | 245-367.5 mg/dose |
| 50kg | 250-375 mg/dose |
Alternatives. Albendazole is the drug of choice in the cited article; mebendazole at 40-50 mg/kg/day is the alternative and is the less-used of the two.
Egyptian National Drug Formulary - Antimicrobial 2023 (albendazole monograph, p26)
The cited article names albendazole as the drug of choice for hydatid disease at 10-15 mg/kg/day, with mebendazole 40-50 mg/kg/day as the other option. The formulary's albendazole monograph names cystic hydatid disease of the liver, lung and peritoneum caused by the larval form of the dog tapeworm as an indication and gives the weight-based rule below, so the drug, the indication and the dose all come from named documents. Drug treatment alone is for cysts the article calls CE1 and CE3a under 5 cm in liver or lung, for disease in two or more organs, and for a patient who cannot have surgery; it is also given around surgery or a percutaneous procedure to stop the cyst coming back.
- DO NOT GIVE IT TO SHRINK A CYST THAT MIGHT BURST. The cited article says benzimidazole treatment is contraindicated in cysts vulnerable to rupture, and in early pregnancy.
- THIS IS NOT A DECISION TO MAKE ALONE. Which cyst is treated with a drug, which with surgery and which with the PAIR needle procedure depends on the ultrasound stage. Anaphylaxis is a real risk if a cyst is punctured or leaks, and the article says the operator must be equipped to deal with it.
- Monitor while on treatment: the cited article asks for white cell count, liver transaminases and ultrasound every 3 to 6 months at first, then yearly once stable.
- Do not give to anyone with a known allergy to albendazole or another benzimidazole.
- Mebendazole 40-50 mg/kg/day is the alternative the article gives if albendazole cannot be used.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| ALBENDAZOLE 400 MG 6 TABS | PHARMA CURE PHARMACEUTICALS > PHARMA CURE | 46.00 EGP (7.67/unit) |
| ANTIZOLE 100MG/5ML SUSP. 30ML? strength differs? different route - not oral solid | ALEXANDRIA | 19.00 EGP |
| ALZENTAL 20MG/ML SUSP. 20ML? strength differs? different route - not oral solid | EIPICO | 21.00 EGP |